Regulation 3(2)
SCHEDULE 1Amendment to Annex 3
| “321 | Methyl-N-methylanthranilate | 85-91-6 | 201-642-6 | (a) Leave-on products | 0.1% | For leave on products only: Not to be used in sunscreen products and products marketed for exposure to natural or artificial UV light. | ||
| (b) Rinse-off products | 0.2% | For leave-on and rinse-off products: | ||||||
|
Regulation 3(3)
SCHEDULE 2Amendment to Annex 6
| “33 | 1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone | Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine | 919803-06-8 | 485-100-6 | 10% | In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %. | ||
| Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation. | ||||||||
| 34 | 1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone | Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano) | 919803-06-8 | 485-100-6 | 10% | Only nanomaterials having the following characteristics are allowed: | ||
| ||||||||
| Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation. | ||||||||
| In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %. ” |
